Blueprint Medicines entered the industry of Drug Brokers in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417112, which describes it as a Drug Brokers. For further clarification, the SIC classifies this business under the code 5122 and described it as a Drug Brokers. The business provides service to the B2B market.
To acquire more information, please contact Chris Varma, Chief Executive Officer by calling (617) 374-7580 during business hours. You can also write to the business’ Single Location at 215 1st St, Cambridge, Massachusetts MA 02142. You can also visit the company’s website at blueprintmedicines.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Blueprint Medicines |
| Representative: | Chris Varma, Chief Executive Officer |
| Place of Business: | 215 1st St, Cambridge, MA 02142 |
| Contact Number: | (617) 374-7580 |
| Website: | blueprintmedicines.com |
| Type of Service: | Drug Brokers |
| SIC Number: | 5122 |
| NAICS Number: | 5417112 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2011 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Blueprint Medicines is a company operating from Middlesex, Massachusetts providing professional Drug Brokers and relevant B2B variables. It was founded in 2011 and registered with the SIC code 5122 as Drug Brokers, and with the NAICS code 5417112 as Drug Brokers.
With a current employee count of 1 to 4, Blueprint Medicines has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Chris Varma, Chief Executive Officer at (617) 374-7580 for related queries, or to locate its Single Location using the coordinates 42.36428,-71.0785.
The Single Location can also be found at the street address 215 1st St in Cambridge, Massachusetts 02142 and can be engaged online through the company website at blueprintmedicines.com, the company Twitter , and Facebook page .